Page last updated: 2024-08-26

1-methyl-1,2,3,4-tetrahydroisoquinoline and Nerve Degeneration

1-methyl-1,2,3,4-tetrahydroisoquinoline has been researched along with Nerve Degeneration in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antkiewicz-Michaluk, L; Bojarski, A; Michaluk, J; Romaska, I; Vetulani, J; Wardas, J1
Dostert, P; Nagatsu, T; Naoi, M; Yoshida, M1

Other Studies

2 other study(ies) available for 1-methyl-1,2,3,4-tetrahydroisoquinoline and Nerve Degeneration

ArticleYear
Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone.
    The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:2

    Topics: Animals; Basal Ganglia Diseases; Brain Chemistry; Dopamine; Injections; Injections, Subcutaneous; Male; Medial Forebrain Bundle; Neostriatum; Nerve Degeneration; Neuroprotective Agents; Presynaptic Terminals; Rats; Rats, Wistar; Rotenone; Serotonin; Stereotaxic Techniques; Substantia Nigra; Tetrahydroisoquinolines; Uncoupling Agents

2004
N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
    Advances in neurology, 1993, Volume: 60

    Topics: Animals; Brain; Cell Death; Culture Techniques; Dopamine; Humans; Isoquinolines; Methylation; Methyltransferases; Monoamine Oxidase; Nerve Degeneration; Parkinson Disease; Rats; Receptors, Dopamine; Substantia Nigra; Tetrahydroisoquinolines

1993